Schmidts hope is that by interrupting these reward signals, GLP-1 medications can help a patient stop or reduce craving-induced relapse during withdrawal
Sources An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 Eli Lilly and Company March 12, 2026 Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks Reuters March 12, 2026
But whats happening in real life is also telling
Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne
Obesity has been associated with conditions like stroke and heart attack, hypertension, breathing difficulties, sleep apnea and an increased risk of early death
In other words, the GLP-1 era just got a little simpler